![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Achieve Clinical Research ![]() Related Tags Alabama
Birmingham Birmingham clinical trials Chronic Obstructive Pulmonary Disease Clinical Studies Copd Diabetes Diabetes Clinical Study Diabetes Clinical Trial Gastroesophageal Reflux Disease Gerd Lupus Clinical Study Lupus clinical trial Nicotine Addiction Smoking Cessation Type 2 Diabetes
| Achieve Clinical Research Latest News+ XML/RSSBy Achieve Clinical Research This trial is a 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naïve subjects with T2DM inadequately controlled on a maximum tolerated dose or maximum dose according to label of GLP-1. By Achieve Clinical Research The primary objective of this 22 week study is to investigate the change in glycosylated hemoglobin (HbA1c) after receiving the new drug, as compared to those receiving a placebo. By Don Smith Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for smoking cessation. By Don Smith Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with COPD. By Don Smith Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with diabetes. | ||||||||||||||||||||||